ANVS Stock Analysis: Buy, Sell, or Hold?
ANVS - Annovis Bio, Inc.
$1.92
0.05 (2.67%)
▲
5d:
+15.66%
30d:
-28.09%
90d:
-33.56%
HOLD
MODERATE Confidence
Analysis Updated: Apr 20, 2026 12:00 AM ET
Earnings: May 12, 2026
20d
Smart Money Distribution
ANVS is up 8.5% this week, but smart money is buying puts. Top strike: $2.5 2026-05-15 with 25 OI. Put ratio: 100% View Scanner →
Strength: 9.2/10
Get Alerted When ANVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ANVS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ANVS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ANVS is currently trading at $1.92, which is considered slightly low relative to its 30-day fair value range of $1.83 to $2.54.
Technical Outlook: Technically, ANVS is in a strong downtrend. Immediate support is located at $1.54, while resistance sits at $2.42.
Market Sentiment: ANVS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.50 (+551.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ANVS is in a strong downtrend. Immediate support is located at $1.54, while resistance sits at $2.42.
Market Sentiment: ANVS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.50 (+551.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.83 -
$2.54
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 551.0% below Wall St target ($12.50)
Fair Price Analysis
30-Day Fair Range
$1.83 -
$2.54
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.54
Resistance Level
$2.42
Current Trend
Strong Downtrend
Technical data as of
Apr 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.41
Wall Street Target
$12.50
(+551.0%)
Share & Embed Analysis
Last updated: April 21, 2026 4:40 AM ET
Data refreshes hourly during market hours. Next update: 5:40 AM
Data refreshes hourly during market hours. Next update: 5:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANVS showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael B Hoffman
BUY
713800 shares
2026-04-02
Michael B Hoffman
BUY
45000 shares
2025-12-08
Michael B Hoffman
BUY
39200 shares
2025-11-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$98 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 61 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 64 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
